Schleswig-Holstein Excellence-Chairs In 2015 Kiel University and the University of Lübeck called for nominations for eight Schleswig-Holstein Excellence Chairs in a joint competition. In the context o
Clinician Scientists The promotion of clinician scientists plays a central role in the Cluster of Excellence PMI. There is a deficit throughout Germany of these specialists who research at an internat
Active agent developed in the Cluster of Excellence PMI is successful in clinical study Placebo-controlled phase II study confirmed efficacy of olamkicept in patients with ulcerative colitis . Ulcerat
TI-2: Integrative Immmunogenetics and Cellular Approaches toward Developing an Antigen-Specific Therapy Coordinators: P. Bacher (CAU), Andre Franke (CAU), A. Scheffold (CAU), T. Lenz (MPI) The members
CD-2: Tryptophan Metabolism and Inflammation Coordinators: M. Laudes (CAU), S. Krauss-Etschmann (RCB, CAU), S. Nikolaus (CAU) In CD-2, clinical feasibility studies are prepared and carried out with th
Genotoxic E. coli “caught in the act” of transforming primary colon cells A research team led by Kiel senior professor and member of PMI Thomas F. Meyer reveals transformation of colon organoids in v
Kiel genome sequencing center transitions to second round of funding The DFG is providing further funding for the Competence Centre for Genomic Analysis Kiel (CCGA Kiel) at Kiel University until 2023.